GUIDED THERAPEUTICS, INC. (GTHP)

Import this data to Google Sheets with:

=jivedata("GTHP","financials")

Full statements spill as a table. For one cell: =jivedata("GTHP","Revenue") or =jivedata("GTHP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

GUIDED THERAPEUTICS, INC.

GTHP • CIK 0000924515

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$98	$7	$767	$650
Cost of Goods and Services Sold	$62	$5	$196	$158
Gross Profit	$36	$2	$571	$492
Net Income (Loss) Attributable to Parent	$-3,489	$-2,417	$-3,196	$-3,065
Dividends, Preferred Stock	$171	$174	$150	$117
Net Income (Loss) Available to Common Stockholders, Basic	$-3,759	$-2,591	$-3,346	$-3,644
Weighted Average Number of Shares Outstanding, Basic	—	—	78,414,000	97,527,000
Weighted Average Number of Shares Outstanding, Diluted	51,131,000	57,339,000	78,414,000	97,527,000
Research and Development Expense	$228	$526	$469	$340
Selling and Marketing Expense	$268	$287	$169	$90
General and Administrative Expense	$2,997	$1,297	$2,305	$2,259
Operating Expenses	$3,493	$2,110	$2,943	$2,467
Operating Income (Loss)	$-3,457	$-2,108	$-2,372	$-1,975
Interest Expense	$278	$381	$617	$601
Interest Income, Other	—	—	$0	$0
Derivative, Gain (Loss) on Derivative, Net	—	—	$65	$4
Gain (Loss) on Extinguishment of Debt	$0	—	$-533	$-501
Other Income	—	—	$165	$-4.525
Other Nonoperating Income (Expense)	$39	$18	$-824	$-1,311
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	$-2,417	$-3,196	$-3,065
Income Tax Expense (Benefit)	$0	$0	$0	$0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$591	$388	$63	$12
Accounts Receivable, after Allowance for Credit Loss, Current	$7	$3	$4	$4
Inventory, Net	$632	$633	$448	$500
Other Assets, Current	$163	$173	$90	$11
Assets, Current	$1,393	$1,197	$605	$527
Property, Plant and Equipment, Net	$32	$23	$16	$11
Operating Lease, Right-of-Use Asset	$227	$141	$686	$640
Other Assets, Noncurrent	$17	$17	$17	$17
Assets, Noncurrent	$276	$181	$719	$668
Assets	$1,669	$1,378	$1,324	$1,195
Accounts Payable, Current	$1,991	$2,094	$2,416	$2,347
Accrued Liabilities, Current	$970	$1,011	$1,718	$1,242
Deferred Revenue, Current	$424	$849	$189	$189
Operating Lease, Liability, Current	$91	$106	$45	$81
Convertible Notes Payable, Current	—	—	$347	$296
Derivative Liability, Current	—	$118	$37	$36
Liabilities, Current	$4,809	$6,155	$6,636	$6,169
Operating Lease, Liability, Noncurrent	$155	$49	$651	$602
Notes Payable, Noncurrent	—	$47	$23	$11
Convertible Debt, Noncurrent	$0	$14	$0	$0
Liabilities, Noncurrent	$666	$112	$694	$789
Liabilities	$5,475	$6,267	$7,330	$6,958
Common Stock, Value, Issued	$3,441	$3,452	$3,471	$3,481
Additional Paid in Capital	$140,983	$142,501	$146,092	$148,843
Stockholders' Equity before Treasury Stock	—	—	$-132	$-132
Retained Earnings (Accumulated Deficit)	$-151,118	$-153,709	$-157,055	$-158,672
Stockholders' Equity Attributable to Parent	$-3,806	$-4,889	$-6,006	$-5,763
Accounts Receivable, Allowance for Credit Loss	$1.5	—	$4	$4
Inventory Valuation Reserves	$818	$818	$818	$818
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Issued	54,105,000	65,131,000	86,154,000	96,537,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-3,489	$-2,417	$-3,196	$-3,065
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$-1,722	—	$-325	$-173
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$591	$388	$63	$317
Accounts Receivable, Credit Loss Expense (Reversal)	—	—	$6	$5
Depreciation	$9	$9	$10	$9
Amortization of Debt Issuance Costs and Discounts	$130	$93	$244	$197
Share-based Payment Arrangement, Expense	$235.98	—	$377	$377
Derivative, Gain (Loss) on Derivative, Net	—	—	$65	$4
Operating Lease, Right-of-Use Asset, Amortization Expense	$76	$86	$97	$96
Gain (Loss) on Extinguishment of Debt	$0	—	$-533	$-501
Other Noncash Expense	—	—	$33	$32
Payments to Acquire Property, Plant, and Equipment	$0	—	$2	$2
Net Cash Provided by (Used in) Investing Activities	—	—	$-2	$-2
Proceeds from Notes Payable	—	$512	$588	$528
Proceeds from Related Party Debt	—	—	$160	$160
Repayments of Notes Payable	$412	$438	$499	$624
Repayments of Related Party Debt	$25	—	$41	$43
Payments of Debt Issuance Costs	—	$29	$30	$30
Proceeds from Issuance of Common Stock	$0	—	$567	$362
Net Cash Provided by (Used in) Financing Activities	$24	$916	$745	$1,333
Interest Paid, Excluding Capitalized Interest, Operating Activities	$107	$51	$61	$64
Increase (Decrease) in Accounts Receivable	$3	$-6	$7	$0
Increase (Decrease) in Inventories	$84	$1	$-185	$-95
Increase (Decrease) in Other Current Assets	$103	$-120	$-208	$-137
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$43	$545	$1,363	$1,131
IncreaseDecreaseInOperatingLeaseLiability	$-79	$-92	$-100	$-62
Increase (Decrease) in Deferred Revenue	$-85	$425	$-660	$-490
Net Cash Provided by (Used in) Operating Activities	$-1,746	$-1,119	$-1,068	$-1,504

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("GTHP","financials")

Full statements spill as a table. For one cell: =jivedata("GTHP","Revenue") or =jivedata("GTHP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.